JBS N.V. Class A Common Shares vs James Hardie Industries plc. Ordinary Shares — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.86B), while James Hardie Industries plc. Ordinary Shares trades at $24.56 (market cap $14.32B). The key difference: JBS N.V. Class A Common Shares and James Hardie Industries plc. Ordinary Shares are close in size by market cap, and JBS N.V. Class A Common Shares pays a 10.38% dividend while James Hardie Industries plc. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and James Hardie Industries plc. Ordinary Shares for 6 Days on average.
| JBS | JHX | |
|---|---|---|
Market Cap | $13.86B | $14.32B |
Volume | 4,980,049 | 5,683,820 |
Sector | Consumer Staples | Basic Materials |
52-Week High | $18.42 | $31.08 |
52-Week Low | $10.86 | $16.69 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $34.83B | $18.55B |
Dividend Yield | 10.38% | — |
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
James Hardie Industries (JHX) trades at $24.67, down 0.36% with a bearish technical outlook. The stock shows mixed fundamentals with a high P/E ratio of 112.14 but strong revenue growth from $3.88B to $5.4B projected. Recent earnings beat expectations in Q2 2026, and the company completed strategic divestitures including the $980M Fermacell sale to Holcim. Analyst sentiment remains positive with 70.59% buy ratings and a $34 consensus price target representing 38% upside potential.
JHX presents a growth story with expanding revenues but faces profitability compression as net margins decline from 10.93% to 2.69%. The stock's high valuation multiples require strong execution to justify. Key risks include integration challenges from recent acquisitions, rising debt levels, and housing market sensitivity. Institutional ownership shows mixed signals with State Street reducing its position while short interest increased 47.8% in September 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.
Read more on JHX →